Ambiorix1
07 Mar 2018
Tosca buys more again bit by bit... up to above 29%. How long before a final bid from.... ?I wonder...Ambiorix.
Madoff Jnr
02 Mar 2018
previous messenger.......! Hi there,I've been here since Medeva days so a long time......Question is 'How much is this business worth'... ...now and in the future....?Seeing someone building a stake maybe good news,but then of course depends if they get business on the cheap.Any thoughts,
Ambiorix1
02 Mar 2018
29% A few months ago, I wrote this :I.M.O. Tosca is not out of the game at all. They sold 5% of Sinclair down to 24.5% but they are now buying again. I think they sold those 5% to ‘a friend’, knowing that in case of a major move this ‘friend’ is going to vote in favor of Tosca’s proposition. Now they are free to buy up again towards 29%. ...And here we are: Tosca up to 29% again. Is this the start of the final move... Could be a last occasion to buy on the cheap.Ambiorix.
charlus
17 Jan 2018
Director buys Nice to see the CEO, his missus and a non exec put some more skin in the game by buying 200K each. CEO now has about 2% of the company. This on the back of a pretty decent trading statement makes me feel quite positive for the future.Only fly in ointment is the Numis note with a target price of 21p.Sales increasing across most product lines by healthy percentages and moving to EBITDA profitability and a broker puts out a note with a target price lower then the current price??? What a bunch of monkeys!Cheers,Chozza
PharmaD
23 Oct 2017
CE registration RNS: 19/10/2017: New CE mark granted for Silhouette Soft®. Probably what has prompted the move up as people realise that the product has a globally recognised status as an EU approved medical device. Sales should be good on the back of this news. Well done Sinclair from someone who knows a bit about audit of companies who are trying to get (re-get) the CE mark.
Red Ninja
19 Sep 2017
Re: Interims Pretty much what the trading update said in July.It didn't impress the markets then as judged by the drift downwards.
charlus
19 Sep 2017
Interims Revenue up 16%, strong 2nd half growth forecast and prediction of EDITDA profit for full year 2017.Slight worry that they have pretty much burnt through their cash pile though.GLA,Chozza
Ambiorix1
06 Jul 2017
Re: ohhhhh I.M.O. Tosca is not out of the game at all. They sold 5% of Sinclair down to 24.5% but they are now buying again. I think they sold those 5% to ‘a friend’, knowing that in case of a major move this ‘friend’ is going to vote in favor of Tosca’s proposition. Now they are free to buy up again towards 29%. Another striking coincidence is the SP. Since Sinclair became an aesthetics company and left pharmaceuticals, the SP is quietly mimicking the SP of Almirall (Spain). Have a look at the chart of both Sinclair and Almirall, striking isn't it ?Anyway, I still expect Sinclair to be taken over rather soon. After all Tosca is probably not going to stay invested in Sinclair for a very long period. Ambiorix.
Madoff Jnr
03 Jul 2017
ohhhhh spoke to soonback down now.....!!!Madoff j
Madoff Jnr
02 Jul 2017
umm,nice rise friday Wonder why the s/p went up 2p today...?I go all the way back to Medeva years and years ago (please don't remind me how long) then it was I.S. pharma I think,then Sinclair I S Pharma,now Sinclair Pharma....!Figures maybe out soon perhaps....?Think as I've been here sooooo long I deserve a return on my investment.Any idea's about how high this share could go anyone....?
whitehat
26 Jun 2017
Re: Tosca Asset Management Been in here for a couple of years now and investment still flat as a pancake. When is this going to move? This acquisition seems not to have gone down too well.Anyone got any ideas to share?
gobbie
14 Jun 2017
Re: Tosca Asset Management Down to 24. They are selling. Previously as high as 29%
charlus
14 Jun 2017
Tosca Asset Management shareholding now up to 24%. Will they build to 30% and trigger a bid?As I understand it they would then have to offer cash to all other shareholders at the highest price they had paid for any shares over the previous 12 months.Sadly for me that would result is a substantial loss on my purchase price of 63p back when they were Acambis (?), so long ago I can't remember the original incarnation.Lets hope we see a good SP run up before Tosca get to 30%GLACheers,Chozza
charlus
28 Mar 2017
Research note Very good comprehensive research note posted under today's RNS. Worth a read for anyone with an interest in SPH, of which there appears to be very few.Chozza
charlus
20 Mar 2017
Volume Huge volume (over 9M) traded so far this morning, and price still rising.Lokks like others are anticipating good results tomorrow.GLA
